Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Samir S. Taneja

doi:10.1097/01.JU.0000611504.41578.ee

Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	32-33
Number of pages	2
Journal	Journal of Urology
Volume	203
Issue number	1
DOIs	https://doi.org/10.1097/01.JU.0000611504.41578.ee
State	Published - Jan 1 2020

ASJC Scopus subject areas

Urology

Access to Document

10.1097/01.JU.0000611504.41578.ee

Cite this

@article{4ac4190f9d4243ce8174df5641865d7d,

title = "Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer",

author = "Taneja, {Samir S.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1097/01.JU.0000611504.41578.ee",

language = "English (US)",

volume = "203",

pages = "32--33",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Re

T2 - Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

AU - Taneja, Samir S.

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85076331145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076331145&partnerID=8YFLogxK

U2 - 10.1097/01.JU.0000611504.41578.ee

DO - 10.1097/01.JU.0000611504.41578.ee

M3 - Comment/debate

C2 - 31634064

AN - SCOPUS:85076331145

SN - 0022-5347

VL - 203

SP - 32

EP - 33

JO - Journal of Urology

JF - Journal of Urology

IS - 1

ER -

Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this